FTX-6746
FTX-6746 is an orally active PPARG inhibitor. FTX-6746 shows potent tumor inhibition in mouse xenograft models[1].
Product Specifications
CAS Number
2829349-96-2
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ftx-6746.html
Purity
98.68
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
ClC(C=CC(C#N)=C1)=C1C2=CC(C3=C(F)C=C(F)C=C3N2)=O
Molecular Formula
C16H7ClF2N2O
Molecular Weight
316.69
References & Citations
[1]Mertz J, et al. Novel inhibitors of the luminal lineage transcription factor peroxisome proliferator-activated receptor gamma (PPARG) durably eradicate tumors in urothelial cancer (UC) animal models[J]. European Journal of Cancer, 2022, 174: S33-S34.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PPARγ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![GDI1 Mouse Monoclonal Antibody [Clone ID: OTI8B2]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908a12/imageurl/cf811045.webp)
BNC881026-500 1x 500 µL
CD70 (TNFS7/1026), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details